tiprankstipranks
Trending News
More News >
AN2 Therapeutics, Inc. (ANTX)
NASDAQ:ANTX
US Market

AN2 Therapeutics, Inc. (ANTX) Income Statement

Compare
93 Followers

AN2 Therapeutics, Inc. Income Statement

Last quarter (Q1 2025), AN2 Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, AN2 Therapeutics, Inc.'s net income was $-10.65M. See AN2 Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ -77.00K$ 0.00$ 0.00
Operating Expenses
$ 54.55M$ 69.64M$ 42.26M$ 21.57M$ 7.28M
Depreciation and Amortization
$ 0.00$ 69.64M$ 77.00K$ 21.57M$ 7.28M
EBITDA
$ -51.32M$ 4.90M$ -42.26M$ -21.57M$ -6.32M
Operating Income
$ -54.55M$ -69.64M$ -42.26M$ -21.57M$ -7.28M
Other Income/Expenses
$ 3.23M$ 4.90M$ 1.31M$ 31.00K$ -6.32M
Pretax Income
$ -51.32M$ -64.73M$ -40.96M$ -21.54M$ -13.60M
Net Income
$ -51.32M$ -64.73M$ -40.96M$ -21.54M$ -13.60M
Per Share Metrics
Basic EPS
$ -1.72$ -2.74$ -2.79$ -1.55$ -0.97
Diluted EPS
$ -1.72$ -2.74$ -2.79$ -1.55$ -0.97
Weighted Average Shares Outstanding
29.83M 23.60M 15.34M 18.74M 18.74M
Weighted Average Shares Outstanding (Diluted)
29.83M 23.60M 15.34M 18.74M 18.74M
Currency in USD

AN2 Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis